Literature DB >> 2194783

Endocrine treatment of breast cancer in women.

R J Santen1, A Manni, H Harvey, C Redmond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2194783     DOI： 10.1210/edrv-11-2-221

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  63 in total

Review 1.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors:  D A Mankoff; F Dehdashti; A F Shields
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.

Authors:  P E Lønning; M Dowsett; A Jones; D Ekse; S Jacobs; F McNeil; D C Johannessen; T J Powles
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  Solving the puzzle of hormone-dependent breast cancer.

Authors:  R J Santen
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 4.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 5.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 6.  Targeted functional imaging in breast cancer.

Authors:  Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

7.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Authors:  Jessica Finlay-Schultz; Austin E Gillen; Heather M Brechbuhl; Joshua J Ivie; Shawna B Matthews; Britta M Jacobsen; David L Bentley; Peter Kabos; Carol A Sartorius
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

9.  Demethylation of promoter C region of estrogen receptor alpha gene is correlated with its enhanced expression in estrogen-ablation resistant MCF-7 cells.

Authors:  Tetsuya Sogon; Shigeru Masamura; Shin-Ichi Hayashi; Richard J Santen; Kei Nakachi; Hidetaka Eguchi
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-16       Impact factor: 4.292

10.  Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.

Authors:  M A Christine Pratt; Tanya E Bishop; Dawn White; Gordon Yasvinski; Michel Ménard; Min Ying Niu; Robert Clarke
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.